Webinar: Introduction to the
Gene and Cellular Therapy Era

Gene and cellular treatments bring unique challenges to the health care delivery model and will drive the need for new innovations, business models and partnerships in practice. Examples of these challenges include the multimillion-dollar wholesale acquisition price for a single dose gene therapy treatment and the introduction of innovative payment options, such as installment-based payments that amortize payment over time and value-based refunds that return financial value to the payer if a therapy fails to meet the expected results.

This webinar will outline the available therapies, review the therapeutic pipeline of investigational medications and describe the unique challenges that gene and cellular therapies introduce.

Learning Objectives

List the current gene and cellular therapies FDA approved and mechanisms of action
Discuss operational and payer considerations unique to gene and cellular therapy program implementation
Describe innovative payment models under consideration for cell and gene therapy
Understand gene therapies expected to launch in the next year